METHODS TO PREDICT CLINICAL OUTCOME OF CANCER

    公开(公告)号:EP4350001A2

    公开(公告)日:2024-04-10

    申请号:EP23213439.5

    申请日:2010-11-19

    IPC分类号: C12Q1/68

    摘要: The present invention provides methods to determine the prognosis and appropriate treatment for patients diagnosed with cancer, based on the expression levels of one or more biomarkers. More particularly, the invention relates to the identification of genes, or sets of genes, able to distinguish breast cancer patients with a good clinical prognosis from those with a bad clinical prognosis. The invention further provides methods for providing a personalized genomics report for a cancer patient. The inventions also relates to computer systems and software for data analysis using the prognostic and statistical methods disclosed herein.

    METHODS TO PREDICT CLINICAL OUTCOME OF CANCER

    公开(公告)号:EP3739060A1

    公开(公告)日:2020-11-18

    申请号:EP20177718.2

    申请日:2010-11-19

    IPC分类号: C12Q1/68

    摘要: The present invention provides methods to determine the prognosis and appropriate treatment for patients diagnosed with cancer, based on the expression levels of one or more biomarkers. More particularly, the invention relates to the identification of genes, or sets of genes, able to distinguish breast cancer patients with a good clinical prognosis from those with a bad clinical prognosis. The invention further provides methods for providing a personalized genomics report for a cancer patient. The inventions also relates to computer systems and software for data analysis using the prognostic and statistical methods disclosed herein.

    METHODS OF PREDICTING CANCER RISK USING GENE EXPRESSION IN PREMALIGNANT TISSUE
    7.
    发明公开
    METHODS OF PREDICTING CANCER RISK USING GENE EXPRESSION IN PREMALIGNANT TISSUE 审中-公开
    基因表达在肿瘤组织中预测癌症风险的方法

    公开(公告)号:EP2417271A2

    公开(公告)日:2012-02-15

    申请号:EP10762395.1

    申请日:2010-04-07

    IPC分类号: C12Q1/68 G01N33/53

    CPC分类号: C12Q1/6886 C12Q2600/158

    摘要: The present disclosure provides methods for assessing a patient's cancer risk and/or recurrence risk, which methods comprise assaying, in a biological sample obtained from the gastrointestinal (GI) tract of the patient, an expression level of a risk gene. The present disclosure also provides methods involving a cancer risk/recurrence risk sequence, i.e. the V600E mutation of the BRAF gene, which is useful for assessing cancer risk and/or recurrence risk in a patient.

    摘要翻译: 本公开提供了用于评估患者的癌症风险和/或复发风险的方法,所述方法包括在从患者的胃肠(GI)道获得的生物样品中测定风险基因的表达水平。 本公开还提供涉及癌症风险/复发风险序列的方法,即BRAF基因的V600E突变,其可用于评估患者的癌症风险和/或复发风险。

    METHODS TO PREDICT CLINICAL OUTCOME OF CANCER
    10.
    发明公开
    METHODS TO PREDICT CLINICAL OUTCOME OF CANCER 审中-公开
    方法用于预测癌症的临床开发

    公开(公告)号:EP2504451A2

    公开(公告)日:2012-10-03

    申请号:EP10832289.2

    申请日:2010-11-19

    IPC分类号: C12Q1/68

    摘要: The present invention provides methods to determine the prognosis and appropriate treatment for patients diagnosed with cancer, based on the expression levels of one or more biomarkers. More particularly, the invention relates to the identification of genes, or sets of genes, able to distinguish breast cancer patients with a good clinical prognosis from those with a bad clinical prognosis. The invention further provides methods for providing a personalized genomics report for a cancer patient. The inventions also relates to computer systems and software for data analysis using the prognostic and statistical methods disclosed herein.